Analyst Ratings for Esperion Therapeutics (ESPR)

ESPR Rating Summary

ESPR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ESPR
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $49.82 (+124.9%) * Over Last 12-Mos
Rating Score: 4.4 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/5/2021 Stifel Derek C. Archilia Downgrade Hold
(Buy)
20.00
(37.00)
26.70
(22.15)
-17.04% Details
4/26/2021 Credit Suisse
» Updated 5/5/2021
Judah C. Frommer New Coverage Outperform
(N/A)
36.00
(45.00)
27.51
(22.15)
-19.48% Details
Like ESPR Ratings? Also take a look at URI, ROP, ROK, PNC

ESPR Ratings News